<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US5393529 - Sustained release - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Sustained release"><meta name="DC.contributor" content="Hans-Rainer Hoffmann" scheme="inventor"><meta name="DC.contributor" content="Robert P. Klein" scheme="inventor"><meta name="DC.contributor" content="Reinhold Meconi" scheme="inventor"><meta name="DC.contributor" content="Gunter Cordes" scheme="inventor"><meta name="DC.contributor" content="Hans M. Wolff" scheme="inventor"><meta name="DC.contributor" content="Lts Lohmann Therapie-Systeme Gmbh &amp; Co. Kg" scheme="assignee"><meta name="DC.contributor" content="Schwarz Pharma Ag" scheme="assignee"><meta name="DC.date" content="1993-6-8" scheme="dateSubmitted"><meta name="DC.description" content="The present invention relates to active substance plasters for the controlled release of active substances to the skin consisting of a backing layer, an adhesive film connected therewith which film is water-soluble and consists of pressure-sensitive adhesive which comprises water-swellable polymers and in which the active substance is at least partially soluble, and of a removable protective layer covering the adhesive film, in which plasters the pressure-sensitive adhesive is based on homo and/or copolymers with at least one derivative of the acrylic or methacrylic acid, and which comprise as active substances, partially or completely dissolved in the adhesive, at a concentration of 0.5 to 10.0%-wt estrogens and their pharmaceutically acceptable derivatives alone or in combination with gestagens."><meta name="DC.date" content="1995-2-28" scheme="issued"><meta name="DC.relation" content="EP:0072251:A2" scheme="references"><meta name="DC.relation" content="EP:0186019:A2" scheme="references"><meta name="DC.relation" content="GB:2094809" scheme="references"><meta name="DC.relation" content="US:4039705" scheme="references"><meta name="DC.relation" content="US:4687481" scheme="references"><meta name="DC.relation" content="US:4810499" scheme="references"><meta name="DC.relation" content="US:4818540" scheme="references"><meta name="DC.relation" content="US:4906169" scheme="references"><meta name="DC.relation" content="US:4913905" scheme="references"><meta name="DC.relation" content="WO:1982000005:A1" scheme="references"><meta name="citation_reference" content="&quot;National Adhesives&quot; technical bulletin, DUROTAK."><meta name="citation_reference" content="National Adhesives technical bulletin, DUROTAK."><meta name="citation_patent_number" content="US:5393529"><meta name="citation_patent_application_number" content="US:08/074,698"><link rel="canonical" href="http://www.google.com/patents/US5393529"/><meta property="og:url" content="http://www.google.com/patents/US5393529"/><meta name="title" content="Patent US5393529 - Sustained release"/><meta name="description" content="The present invention relates to active substance plasters for the controlled release of active substances to the skin consisting of a backing layer, an adhesive film connected therewith which film is water-soluble and consists of pressure-sensitive adhesive which comprises water-swellable polymers and in which the active substance is at least partially soluble, and of a removable protective layer covering the adhesive film, in which plasters the pressure-sensitive adhesive is based on homo and/or copolymers with at least one derivative of the acrylic or methacrylic acid, and which comprise as active substances, partially or completely dissolved in the adhesive, at a concentration of 0.5 to 10.0%-wt estrogens and their pharmaceutically acceptable derivatives alone or in combination with gestagens."/><meta property="og:title" content="Patent US5393529 - Sustained release"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("jqXtU7GQB4mIogTA0YCACg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("NZL"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("jqXtU7GQB4mIogTA0YCACg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("NZL"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us5393529?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US5393529"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=9RU7BAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS5393529&amp;usg=AFQjCNFGNrgRC8BhxqSviHX7xBVCimff8Q" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5393529.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US5393529.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US5393529" style="display:none"><span itemprop="description">The present invention relates to active substance plasters for the controlled release of active substances to the skin consisting of a backing layer, an adhesive film connected therewith which film is water-soluble and consists of pressure-sensitive adhesive which comprises water-swellable polymers and...</span><span itemprop="url">http://www.google.com/patents/US5393529?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US5393529 - Sustained release</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US5393529 - Sustained release" title="Patent US5393529 - Sustained release"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US5393529 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/074,698</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Feb 28, 1995</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Jun 8, 1993</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Oct 6, 1989</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2027053A1">CA2027053A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2027053C">CA2027053C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE3933460A1">DE3933460A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE3933460C2">DE3933460C2</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE59009495D1">DE59009495D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0421454A2">EP0421454A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0421454A3">EP0421454A3</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0421454B1">EP0421454B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0421454B2">EP0421454B2</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">074698, </span><span class="patent-bibdata-value">08074698, </span><span class="patent-bibdata-value">US 5393529 A, </span><span class="patent-bibdata-value">US 5393529A, </span><span class="patent-bibdata-value">US-A-5393529, </span><span class="patent-bibdata-value">US5393529 A, </span><span class="patent-bibdata-value">US5393529A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Hans-Rainer+Hoffmann%22">Hans-Rainer Hoffmann</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Robert+P.+Klein%22">Robert P. Klein</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Reinhold+Meconi%22">Reinhold Meconi</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Gunter+Cordes%22">Gunter Cordes</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Hans+M.+Wolff%22">Hans M. Wolff</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Lts+Lohmann+Therapie-Systeme+Gmbh+%26+Co.+Kg%22">Lts Lohmann Therapie-Systeme Gmbh & Co. Kg</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Schwarz+Pharma+Ag%22">Schwarz Pharma Ag</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5393529.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5393529.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5393529.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (10),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (2),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (44),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (19),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (7)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/5393529&usg=AFQjCNEuiFnqmuShtRWdqVVGDN-WNR99dA">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D5393529&usg=AFQjCNEJs1XCX8iVEOWkjkD4bP0LXGE-wA">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D5393529A%26KC%3DA%26FT%3DD&usg=AFQjCNFJqXq5VS1BQIBfqnnlSgmdY2h1QA">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129428702" lang="EN" load-source="ifi">Sustained release</invention-title></span><br><span class="patent-number">US 5393529 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA37403947" lang="EN" load-source="patent-office"> <div class="abstract">The present invention relates to active substance plasters for the controlled release of active substances to the skin consisting of a backing layer, an adhesive film connected therewith which film is water-soluble and consists of pressure-sensitive adhesive which comprises water-swellable polymers and in which the active substance is at least partially soluble, and of a removable protective layer covering the adhesive film, in which plasters the pressure-sensitive adhesive is based on homo and/or copolymers with at least one derivative of the acrylic or methacrylic acid, and which comprise as active substances, partially or completely dissolved in the adhesive, at a concentration of 0.5 to 10.0%-wt estrogens and their pharmaceutically acceptable derivatives alone or in combination with gestagens.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(10)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-8.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-8.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5393529-9.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5393529-9.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(8)</span></span></div><div class="patent-text"><div mxw-id="PCLM4829924" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>We claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. In a plaster for the controlled release of an estrogen to the skin and comprising<div class="claim-text">A) an impermeable backing or covering layer,</div> <div class="claim-text">B) a reservoir layer adjacent to, and in close contact with said backing or covering layer, said reservoir layer comprising a water-insoluble pressure-sensitive adhesive polymer layer containing the estrogen in a concentration of about 0.5 to 10 by weight, in combination with at least one water-swellable polymer in 0.01 to 10% wt, and</div> <div class="claim-text">C) a protective layer covering and adhering to said adhesive polymer layer and removable therefrom for the use of said transdemal drug patch, the improvement wherein the pressure-sensitive adhesive polymer of B is a polymer of acrylic or methacrylic acid or an ester thereof, and contains a 0.1 to 20%-wt of at least one substance delaying or preventing the crystallization of the active substance,</div> <div class="claim-text">the water-swellable polymer being selected from the group consisting of galactomannans, cellulose products, tragacanth, polyglycosides, polyvinylpyrrolidones, finely pulverized polyamides, water-soluble polyacrylamide, carboxyvinyl polymers, agar, copolymers of methylvinyl ether and maleic acid anhydride, guar gum, hydroxypropyl guar gum or guar flour, gum arabic, dextrin and dextran, polysaccharide gum, hydroxymethylpropyl cellulose, pectin and pectinamide, and</div> <div class="claim-text">the crystallization delaying or preventing substance being selected from the group consisting of phthalic acid esters, adipic acid esters, monoglycerides, diglycerides, and triglycerides, ester of higher fatty acids, long-chain alcohols, nonylphenol, octylphenol, fatty acids, sorbitol, mannitol, non-ionogenic surfactants, polyoxyethylene alkyl esters, castor oil, sitosterine and polyvinylpyrrolidone.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. A plaster according to claim 1, wherein the polymer of B is cross-linkable.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. A plaster according to claim 1, wherein the polymer of B is a solvent-based pressure-sensitive adhesive.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. A plaster according to claim 1, wherein the polymer of B is a dispersion-based pressure-sensitive adhesive.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. A plaster according to claim 1, wherein the polymer of C is a hot-melt-pressure-sensitive adhesive.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. A plaster according to claim 1, wherein the pressure-sensitive adhesive comprises at least one tackifying resin in an amount of 0.5 to 50%-wt.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. A plaster according to claim 1, wherein the therapeutic substance-containing adhesive film has a thickness of 0.01 to 0.3 mm.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. A plaster according to claim 1, wherein the additionally water-swellable polymer of layer C is selected from the group consisting of galactomannan, microcrystalline cellulose and tragacanth.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES66647345" lang="EN" load-source="patent-office" class="description">
    <p>This application is a continuation of application Ser. No. 07/591,171, filed Oct. 1, 1990, abandoned.</p>
    <heading>DESCRIPTION</heading> <p>The present invention relates to an active substance containing plaster for the controlled release of active substances to the skin consisting of a backing layer being impermeable to the active substance, a pressure-sensitive adhesive containing the active substance(s), and a removable protective layer, as well as to a process for the production of the active substance containing plaster, and to its use for the transdermal application of estrogens, their pharmaceutically acceptable derivatives alone or in combination with gestagens in human medicine.</p>
    <p>Active substance plasters are pressure-sensitive adhesive, galenic preparations to be applied to the skin and which have a fixed application area. They release one or more medicinal agents contained therein to the human or animal body in a controlled manner with respect to time and amount. Such systems, such as are described by Y. W. Chieng, Drug Dev. Ind. Pharm. 13, 589-651 (1987), have proved successful in therapy for years.</p>
    <p>Many of these active substance plasters comprise the active substance in a finely divided form within hydrophobic adhesive films, and thus are conceptionally simple pharmaceutical preparations which can be manufactured by series production.</p>
    <p>Conventional designs of transdermal systems which are already used in practice are:</p>
    <p>a) assembly comprising an impermeable backing layer and a layer simultaneously serving as drug reservoir, pressure-sensitive adhesive, and controlling unit,</p>
    <p>b) construction of backing layer, drug reservoir, controlling unit, and adhesive layer in spatial separation,</p>
    <p>c) assembly comprising backing layer and active substance containing matrix being arranged in a multi-layered form, whereby the active substance concentration becomes lower from layer to layer towards the skin,</p>
    <p>d) construction of backing layer and matrix, whereby the release is controlled by the active substance containing microcapsule being dispersed through the matrix.</p>
    <p>Compared to traditional forms of application, the therapeutic progress of these systems lies in the fact that the active substances are not applied to the body in massive doses, such as is the case, for example, when tablets are taken, but in a continuous way.</p>
    <p>By this, on the one hand, the duration of effect of the medicinal agent is prolonged, on the other hand, side effects are substantially avoided by the prevention of unnecessary blood level peaks.</p>
    <p>If an active substance amount which is higher than the adsorption capacity of the film forming plaster components is incorporated into such a plaster, the active substance is to be distributed within the adhesive matrix as finely as possible up to amorphous, in order to substantially maintain the saturation state of the pressure-sensitive adhesive by rapid subsequent dissolution throughout the duration of application, thus keeping the degree of velocity decrease of the active substance release from the plaster as low as possible. Usually the production of plaster films is carried out in such a way that the adhesive components and the active substance are jointly dissolved in an organic solvent and dried after spreading them on large-surface webs.</p>
    <p>It is known from DE-OS 3205258 and EP 0285563 to administer estradiol and ethanol in a plaster formulation at the same time. However, the design of this plaster is very complicated and it can only be produced in a very expensive way, since the individual components must be manufactured separately and are then joined to form a plaster in a further operation.</p>
    <p>WO 87/07138 describes an estradiol plaster on the basis of a backing layer, an active substance-containing matrix, and a pressure-sensitive adhesive being covered by a removable protective layer. The production of matrix and pressure-sensitive adhesive is carried out by technologically very expensive operations, such as homogenizing, degasification, coating, drying, and separating. According to one embodiment, the backing layer must even be coated with a pressure-sensitive adhesive thus causing a further operation. Joining together the individual components is carried out in a separate step. Thus, the production of this plaster as a whole is very expensive and complicated.</p>
    <p>From U.S. Pat. No. 4,624,665 systems are known which contain the active substance within the reservoir in microencapsulated form. The reservoir is embedded between backing layer and a membrane. The outer edge of the system is provided with a pressure-sensitive adhesive. The construction and the production of these systems is very complicated, since the active substance has to be microencapsulated and homogeneously distributed in a liquid phase which then is embedded between backing layer and membrane by further process steps, In addition, the system is then to be provided with the adhesive edge and covered by a protective layer.</p>
    <p>From EP 186019 active substance plasters are known in which water-swellable polymers are added to a rubber/ adhesive resin mass, and from which estradiol can be released, However, it turned out that the release of estradiol from these active substance plasters was much to low and did not meet the therapeutic requirements,</p>
    <p>It is accordingly the object of the present invention to provide an active substance plaster the active substance release of which meets the therapeutic requirements.</p>
    <p>Surprisingly, this problem has been solved by the provision of an active substance plaster for the controlled release of active substances to the skin consisting of a backing layer, of a water-insoluble adhesive film connected therewith and made of a pressure-sensitive adhesive which comprises water-swellable polymers and in which the active substances are soluble at least partially, and further consisting of a removable protective layer covering the adhesive film. Said plaster is characterized in that the pressure-sensitive adhesive is based on homopolymers and/or copolymers with at least one derivative of the acrylic or methacrylic acid, and that it comprises as active substances at a concentration of 0.5 to 10.0%-wt partially or completely dissolved in the adhesive estrogens and their pharmaceutically acceptable derivatives alone or in combination with gestagens.</p>
    <p>Surprisingly, it turned out that the combination of water-swellable polymers with polymers based on acrylates provided release conditions for the mentioned active substances which, over a longer period of time, guaranteed the release of active substance from the plaster at an amount which was several times over that released according to the state of the art.</p>
    <p>A suitable embodiment may comprise substances delaying or preventing the crystallization of the active substance at a concentration of 0.1 to 20%-wt, preferably 0.5 to 10%-wt, as well as water-swellable polymers at a moiety of 0.01 to 10%-wt, preferably 0.1 to 5%-wt. The tackifying resins are advantageously present at an amount of 0.5 to 50%-wt, preferably 1 to 20%-wt. The thickness of the active substance containing adhesive film may amount from 0.01 to 0.30 mm, preferably 0.04 to 0.20 mm.</p>
    <p>As pressure-sensitive adhesives homopolymers and/or copolymers with at least one derivative of the acrylic or methacrylic acid in the form of solutions in organic solvents may be used, i.e., in non-cross-linkable or in cross-linkable form. The cross-linking agent has the effect that the polymer chains are linked together via reactive groups and that thus the cohesion of the pressure-sensitive adhesive is increased,</p>
    <p>The cross-linkable pressure-sensitive adhesives in the form of organic solutions are preferably polymerized from a combination of the following monomers:</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/butyl acrylate/acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/vinyl acetate/acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/vinyl acetate/acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/vinyl acetate/allyl acrylate,</p>
    <p>2-ethyl hexyl acrylate/vinyl acetate/divinylbenzene/ acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/vinyl acetate/allyl methacrylate/acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/vinyl acetate/2-hydroxyethyl acrylate,</p>
    <p>2-ethyl hexyl 1 acrylate/vinyl acetate/2-hydroxyethyl methacrylate,</p>
    <p>2-ethyl hexyl acrylate/fumaric acid-diethyl ester/ acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/maleic acid-diethyl ester/2hydroxyethyl acrylate.</p>
    <p>As cross-linking agents the following compounds are preferred:</p>
    <p>diphenylmethane-4-diisocyanate, hexamethylene diisocyanate, isophorone diisocyanate, titanium-acetylacetonate, aluminum-acetylacetonate, iron-acetylacetonate, zinc-acetylacetonate, magnesium-acetylacetonate, zirconium-acetylacetonate, 2-ethyl-l,3-hexanediol-titanate, tetraisooctyl titanate, tetranonyl titanate, polyfunctional propyleneimine derivatives, etherified melamine formaldehyde resins, highly methylated urethane resins, imino-melamine resins.</p>
    <p>The non-cross-linkable pressure-sensitive adhesives in the form of organic solutions can advantageously be polymerized, for example, from the combination of the following monomers:</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/vinyl acetate,</p>
    <p>2-ethyl hexyl acrylate/vinyl acetate,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/vinyl acetate/allyl acrylate,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/allyl methacrylate,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/vinyl acetate/divinylbenzene,</p>
    <p>2-ethyl hexyl acrylate/fumaric acid diethyl ester/ allyl acrylate,</p>
    <p>2-ethyl hexyl acrylate/maleic acid diethyl ester/allyl acrylate,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/acrylamide/ vinyl acetate/allyl acrylate,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/isobutyl acrylate/vinyl acetate/allyl acrylate.</p>
    <p>In addition pressure-sensitive adhesives in the form of aqueous dispersions can be used. Their capacity is comparable to that of the solution pressure-sensitive adhesives, however, they have the advantage that in case of coating and drying no inflammable and toxic solvents are formed.</p>
    <p>Pressure-sensitive adhesives in the form of aqueous dispersions, so-called dispersion pressure-sensitive adhesives, can, for example, advantageously be polymerized from the combination of the following monomers:</p>
    <p>n-butyl acrylate/isobutyl acrylate/acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/2-hydroxyethyl acrylamide,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/vinyl acetate/acrylamide,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/vinyl acetate/2-hydroxyethyl acrylate,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/allyl acrylate/acrylic acid,</p>
    <p>2-ethyl hexyl acrylate/n-butyl acrylate/vinyl acetate/divinylbenzene.</p>
    <p>In addition, so-called hot-melt pressure-sensitive adhesives can be used, which are applied out of a melt.</p>
    <p>Examples of water-swellable polymers added to the adhesive mass of the active substance containing plasters according to the present invention are products, such as galactomannans, cellulose products, tragacanth, polyglycosides, polyvinylpyrrolidones, finely pulverized polyamides, water-soluble polyacrylamide, carboxyvinyl polymers, seaweed products similar to agar, copolymers of methylvinyl ether and maleic acid anhydride, guar gum, types like hydroxypropyl guar gum or guar flour, gum arabic, dextrin and dextran, microbiologically recovered polysaccharide gum, such as the polysaccharide B 1459 or the readily water-soluble type Keltrol and synthetically recovered polysaccharides, such as the product Ficoll, respectively, methylglucose derivatives, hydroxymethylpropyl cellulose, polygalacturonic acid derivatives, such as pectin or the amidated product pectinamide.</p>
    <p>In this connection, galactomannans, microcrystalline cellulose and tragacanth are particularly preferred.</p>
    <p>In addition tackifying resins, such as colophony and the derivatives therof, polyterpene resins of α- or β-pinene, aliphatic, aromatic, or alkylaromatic hydrocarbon resins, melamine-formaldehyde resins, phenolic resins, hydroabietyl alcohol, and mixtures thereof can be used as components of the pressure-sensitive adhesive.</p>
    <p>Further components of the pressure-sensitive adhesive may be crystallization inhibitors, such as phthalic acid esters, adipic acid esters, monoglycerides, diglycerides, and triglycerides, ester of higher fatty acids, long-chain alcohols and the derivatives thereof, derivatives of nonylphenol and octylphenol, respectively, derivatives of fatty acids, derivatives of sorbitol and mannitol, non-ionogenic surfactants, polyoxyethylene alkyl ethers, derivatives of castor oil, sitosterine and polyvinylpyrrolidone, as well as other substances known to those skilled in the art.</p>
    <p>The thickness of the active substance containing adhesive film may amount from 0.01 to 0.30 mm, preferably 0.04 to 0.20 mm.</p>
    <p>Suitable materials for the backing layer being impermeable to active substances, for example, are polyester, polyamide, polyethylene, polypropylene, polyurethanes, polyvinylchloride, namely both as so-called solo-foils and as sandwich-foils in combination with foils of different plastic materials. These foils may have a thickness of 0.06 to 0.20 mm, and may additionally be aluminized or laminated with an aluminum foil, respectively.</p>
    <p>Suitable materials for the removable protective layer, for example, are polyester, polyethylene, and polypropylene, as well as papers coated with these materials and optionally aluminized or laminated with an aluminum foil. In addition, the foils or papers, respectively, are coated with silicone, in order to render them removable. These materials are used at a thickness of 0.02 to 0.30 mm. Except for the polyester foils, these materials can also be used as removable intermediate layers. This is necessary, if the elasticity properties of the removable protective layer and the backing layer are insufficient so that in case of rolling up the laminate of backing layer, active substance containing, water-insoluble adhesive mass, and removable protective layer creases within the active substance plaster would arise after coating and drying.</p>
    <p>Suitable active substances according to the present invention are 17 β-estradiol and 17 α-estradiol and the derivatives thereof, respectively.</p>
    <p>Pharmaceutically acceptable derivatives according to the present invention are, amongst others, ester, ether, ethynyl compounds of estradiol, such as:</p>
    <p>estradiol (17β)-17-butyryl acetate,</p>
    <p>estradiol 17 β-cipionate,</p>
    <p>estradiol 3,17β-dienantate,</p>
    <p>estradiol 3,17β-dipropionate,</p>
    <p>estradiolenantate,</p>
    <p>estradiol 3-hydrogensulfate (sodium salt),</p>
    <p>estradiol 17 β-(3-phenylpropionate),</p>
    <p>estradiolundexylate,</p>
    <p>estradiolvalerate,</p>
    <p>estradiol 17 α-(3-oxohexonate),</p>
    <p>epimestrole,</p>
    <p>quinestrol,</p>
    <p>quinestradol,</p>
    <p>ethynylestradiol,</p>
    <p>fosferol, and</p>
    <p>estratriol,</p>
    <p>In addition chlorotrianisen is suitable as estrogen, too.</p>
    <p>Suitable gestagens according to the present invention, for example, are:</p>
    <p>lynestrenol,</p>
    <p>norethisterone,</p>
    <p>hydroxyprogesterone,</p>
    <p>medrogestone,</p>
    <p>progesterone,</p>
    <p>medroxy progesterone acetate,</p>
    <p>gestonorone,</p>
    <p>dydrogesterone,</p>
    <p>chlormadinone,</p>
    <p>allylestrenol,</p>
    <p>megestrol.</p>
    <p>The process for the production of the active substance plaster is carried out in such a way that all components of the active substance containing adhesive mass are homogenized under stirring or kneading, respectively, optionally with the addition of organic solvents in order to dissolve the active substance. The active substance containing adhesive solution or suspension, respectively, so obtained is coated onto the removable protective layer, the backing layer, or the removable intermediate layer, and the solvent is dried off under increased temperature and/or reduced pressure.</p>
    <p>The backing layer, or the removable protective layer, or the removable intermediate layer is laminated on the resulting active substance containing adhesive film.</p>
    <p>The broad rolls obtained after coating and drying, consisting of the completely constituted active substance plaster material are cut to narrow rolls, and then the individual active substance plasters are punched. The manufacture of the individual active substance plasters can also be carried out by format punching from the broad rolls.</p>
    <p>The active substance containing plasters may have any desired shape, for example, a round, oval, elliptic, square, or rectangular shape with rounded edges. The size of the active substance plasters depends on the therapeutic requirements; it may vary from 1 to 50 cm<sup>2</sup>.</p>
    <p>The invention will be illustrated by the following examples:</p>
    <heading>EXAMPLE 1</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________182.342 g cross-linkable pressure-sensitive adhesive     based on homo and/or copolymers with at     least one derivative of the acrylic or meth-     acrylic acid with cross-linking agent     (e.g., Durotak 280-2516),1.64 g    galactomannan (e.g., Meyprogat 90),1.60 g    1,2-propanediol and2.00 g    estradiol are homogenized by stirring in     a beaker under the addition of8.773 g   ethanol and8.773 g   ethyl acetate.______________________________________ 2.00 g estradiol are homogenized by stirring in</pre>
    
    <p>a beaker under the addition of 8,773 g ethanol and 8.773 g ethyl acetate.</p>
    <p>This mass is spread by means of a coating bar on a polyester foil having a thickness of 100 μm which is aluminized one side and coated with silicone on both sides; the mass is dried at 50° C. in a circulating-air-drying-chamber for 10 minutes so that an active substance containing adhesive film having an area weight of 80 g/m<sup>2</sup> results. This film is subsequently covered with a polyester foil of 15 μm thickness. Then individual plasters having a surface of 16 cm<sup>2</sup> are punched out.</p>
    <p>Active substance release</p>
    <p>Plaster sections of 5 cm<sup>2</sup> are used for the measurement of the active substance release.</p>
    <p>On the side of the backing layer the active substance plaster is agglutinated with a polyester foil of 100 μm thickness and, after having pulled-off the removable protective layer, inserted into 80 ml demineralized water of 34° C. After 2, 4, 6, and 24 hours, the demineralized water is changed and the estradiol content in the sample solutions determined by liquid chromatography.</p>
    <p>The results are shown in Table 1.</p>
    <p>The further examples differ in the pressure-sensitive adhesive used. The results of the active substance release are summarized in Table 1.</p>
    <heading>EXAMPLE 2</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________148.00 g  non-cross-linkable pressure-sensitive ad-     hesive based on homo and/or copolymers with     at least one derivative of the acrylic or     methacrylic acid (e.g., Durotak 280-2287)2.40 g    galactomannan (e.g., Meyprogat 90),1.60 g    1,2-propanediol and2.00 g    estradiol are homogenized by stirring in a     beaker under the addition of30.667 g  ethanol and15.337 g  ethyl acetate______________________________________</pre>
    
    <p>Further processing is carried out as described in Example 1.</p>
    <heading>EXAMPLE 3</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________140.26 g  cross-linkable pressure-sensitive adhesive     based on homo and/or copolymers with at     least one derivative of the acrylic or meth-     acrylic acid with cross-linking agent (e.g.,     Durotak 126-1050)1.64 g    galactomannan (e.g., Meyprogat 90),1.60 g    1,2-propanediol and2.00 g    estradiol are homogenized in a beaker by     stirring under the addition of20 ml     ethanol and20 ml     ethyl acetate______________________________________</pre>
    
    <p>Further processing is carried out as described in Example 1.</p>
    <heading>EXAMPLE 4</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________155.43 g  cross-linkable pressure-sensitive adhesive     based on homo and/or copolymers with at     least one derivative of the acrylic or meth-     acrylic acid with cross-linking agent (e.g.,     Durotak 380-1054)1.64 g    galactomannan (e.g., Meyprogat 90),1.60 g    1,2-propanediol and2.00 g    estradiol are homogenized in a beaker by     stirring.______________________________________</pre>
    
    <p>Further processing is carried out as described in Example 1.</p>
    <heading>EXAMPLE 5</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________153.20 g  cross-linkable pressure-sensitive adhesive     based on homo and/or copolymers with at     least one derivative of the acrylic or meth-     acrylic acid with cross-linking agent (e.g.,     Durotak 180-1197B)1.64 g    galactomannan (e.g., Meyprogat 90),1.60 g    1,2-propanediol and2.00 g    estradiol are homogenized by stirring in a     beaker under the addition of20.00 ml  ethanol and20.00 ml  ethyl acetate______________________________________</pre>
    
    <p>Further processing is carried out as described in Example 1.</p>
    <heading>EXAMPLE 6</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________146.88 g  cross-linkable pressure-sensitive adhesive     based on homo and/or copolymers with at     least one derivative of the acrylic or meth-     acrylic acid with cross-linking agent (e.g.,     Aroset 1880-Z-46)1.64 g    galactomannan (e.g., Meyprogat 90),1.60 g    1,2-propanediol and2.00 g    estradiol are homogenized in a beaker by     stirring under the addition of20.00 ml  ethanol and20.00 ml  ethyl acetate______________________________________</pre>
    
    <p>Further processing is carried out as described in Example 1.</p>
    <heading>EXAMPLE 7</heading> <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________139.22 g  cross-linkable pressure-sensitive adhesive     based on homo and/or copolymers with at     least one derivative of the acrylic or meth-     acrylic acid with cross-linking agent (e.g.,     Aroset 1930-TH-46)1.64 g    galactomannan (e.g., Meyprogat 90),1.60 g    1,2-propanediol and2.00 g    estradiol are homogenized by stirring in a     beaker under the addition of30.00 ml  ethanol and30.00 ml  ethyl acetate______________________________________</pre>
    
    <p>Further processing is carried out as described in Example 1.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 1______________________________________Prior art according to EP 0186019 - Example 3 CActive substance release: 0.63 mg/16 cm<sup>2</sup> × 24 hours.Active substance release mg/16 cm<sup>2</sup> afterExample 2 h      4 h      6 h    8 h    24 h______________________________________1       0.67     1.10     1.63   --     2.382       0.77     1.24     1.85   --     2.673       0.88     1.37     --     1.63   2.874       0.74     1.19     --     1.77   2.435       0.62     1.01     --     1.49   2.286       0.66     1.00     --     1.51   2.367       0.81     1.28     --     1.91   2.71______________________________________</pre>
    
    <p>As is demonstrated by the results of Table 1, the active substance release of the plasters according to the present invention--already after 2 hours--is as high as that according to the state of the art is after 24 hours.</p>
    <p>It is understood that the specification and examples are illustrative but not limitative of the present invention and that other embodiments within the spirit and scope of the invention will suggest themselves to those skilled in the art.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4039705">US4039705</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 13, 1976</td><td class="patent-data-table-td patent-date-value">Aug 2, 1977</td><td class="patent-data-table-td ">Avery International Corporation</td><td class="patent-data-table-td ">Sheets and tapes, two differential release surfaces</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4687481">US4687481</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 3, 1986</td><td class="patent-data-table-td patent-date-value">Aug 18, 1987</td><td class="patent-data-table-td ">Biotek, Inc.</td><td class="patent-data-table-td ">Controlled release by way of membrane adhering to skin</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4810499">US4810499</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 5, 1988</td><td class="patent-data-table-td patent-date-value">Mar 7, 1989</td><td class="patent-data-table-td ">Biotek, Inc.</td><td class="patent-data-table-td ">Sustained release</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4818540">US4818540</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 29, 1986</td><td class="patent-data-table-td patent-date-value">Apr 4, 1989</td><td class="patent-data-table-td ">Rutgers, The State University Of New Jersey</td><td class="patent-data-table-td ">Polymer matrix absorber, biocompatible estrogen, progestin hormones; less frequent dosages, sustained release</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4906169">US4906169</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 16, 1988</td><td class="patent-data-table-td patent-date-value">Mar 6, 1990</td><td class="patent-data-table-td ">Rutgers, The State University Of New Jersey</td><td class="patent-data-table-td ">Transdermal estrogen/progestin dosage unit, system and process</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4913905">US4913905</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 25, 1988</td><td class="patent-data-table-td patent-date-value">Apr 3, 1990</td><td class="patent-data-table-td ">Ciba-Geigy Corporation</td><td class="patent-data-table-td ">Transdermal therapeutic systems for active ingredient combinations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0072251A2?cl=en">EP0072251A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 10, 1982</td><td class="patent-data-table-td patent-date-value">Feb 16, 1983</td><td class="patent-data-table-td ">LecTec Corporation</td><td class="patent-data-table-td ">Improved bandage containing a medicament</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0186019A2?cl=en">EP0186019A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 7, 1985</td><td class="patent-data-table-td patent-date-value">Jul 2, 1986</td><td class="patent-data-table-td ">Schwarz Pharma Ag</td><td class="patent-data-table-td ">Medicated dressing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=9RU7BAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DGB%26NR%3D2094809A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNFewQeA9CCj4KK2ijxzbmumr12ufw">GB2094809A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1982000005A1?cl=en">WO1982000005A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 26, 1981</td><td class="patent-data-table-td patent-date-value">Jan 7, 1982</td><td class="patent-data-table-td ">Key Pharma</td><td class="patent-data-table-td ">Polymeric diffusion matrix containing a vasodilator</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">"<a href='http://scholar.google.com/scholar?q="National+Adhesives"'>National Adhesives</a>" technical bulletin, DUROTAK.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">National Adhesives technical bulletin, DUROTAK.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5554381">US5554381</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 9, 1993</td><td class="patent-data-table-td patent-date-value">Sep 10, 1996</td><td class="patent-data-table-td ">Cygnus, Inc.</td><td class="patent-data-table-td ">Low flux matrix system for delivering potent drugs transdermally</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5656286">US5656286</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 7, 1994</td><td class="patent-data-table-td patent-date-value">Aug 12, 1997</td><td class="patent-data-table-td ">Noven Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Solubility parameter based drug delivery system and method for altering drug saturation concentration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5665377">US5665377</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 19, 1994</td><td class="patent-data-table-td patent-date-value">Sep 9, 1997</td><td class="patent-data-table-td ">Giapharma Sa</td><td class="patent-data-table-td ">Administration system for estradiol</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5876746">US5876746</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 6, 1996</td><td class="patent-data-table-td patent-date-value">Mar 2, 1999</td><td class="patent-data-table-td ">Cygnus, Inc.</td><td class="patent-data-table-td ">Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5885612">US5885612</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 18, 1995</td><td class="patent-data-table-td patent-date-value">Mar 23, 1999</td><td class="patent-data-table-td ">Lts Lohmann Therapie-Systeme Gmbh</td><td class="patent-data-table-td ">Recrystallization-free estradiol-containing patch</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5904931">US5904931</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 9, 1995</td><td class="patent-data-table-td patent-date-value">May 18, 1999</td><td class="patent-data-table-td ">Schering Aktiengesellschaft</td><td class="patent-data-table-td ">Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5912008">US5912008</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 16, 1997</td><td class="patent-data-table-td patent-date-value">Jun 15, 1999</td><td class="patent-data-table-td ">Lts Lohmann Therapie-Systeme Gmbh</td><td class="patent-data-table-td ">Laminated structure of backing layer, moisture and impermeable layer, tackifiers and permeation enhancer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5916968">US5916968</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 25, 1997</td><td class="patent-data-table-td patent-date-value">Jun 29, 1999</td><td class="patent-data-table-td ">National Starch And Chemical Investment Holding Corporation</td><td class="patent-data-table-td ">Adhesives resistant to skin-penetration enhancers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5958446">US5958446</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 4, 1995</td><td class="patent-data-table-td patent-date-value">Sep 28, 1999</td><td class="patent-data-table-td ">Noven Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Blend of at least two polymers having differing solubility parameters adjusts the solubility of a drug in the polymeric blend and thereby modulates the delivery of the drug from the system and through the dermis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5980932">US5980932</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 21, 1997</td><td class="patent-data-table-td patent-date-value">Nov 9, 1999</td><td class="patent-data-table-td ">Cygnus, Inc.</td><td class="patent-data-table-td ">Solid matrix system for transdermal drug delivery</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5985311">US5985311</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 22, 1998</td><td class="patent-data-table-td patent-date-value">Nov 16, 1999</td><td class="patent-data-table-td ">Labtec Gesellschaft Fuer Techologische Forschung Und Entwicklung Mbh</td><td class="patent-data-table-td ">Estrogen, a gestagen or androgen, acrylate adhesive and, as resorption promoters, oleic acid and 2-(2-ethoxyethoxy)ethanol.</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6024976">US6024976</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 11, 1997</td><td class="patent-data-table-td patent-date-value">Feb 15, 2000</td><td class="patent-data-table-td ">Noven Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Solubility parameter based drug delivery system and method for altering drug saturation concentration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6071531">US6071531</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 28, 1999</td><td class="patent-data-table-td patent-date-value">Jun 6, 2000</td><td class="patent-data-table-td ">Ortho-Mcneil Pharmaceutical, Inc.</td><td class="patent-data-table-td ">Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6090404">US6090404</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 5, 1995</td><td class="patent-data-table-td patent-date-value">Jul 18, 2000</td><td class="patent-data-table-td ">Lts Lohmann Therapie-Systeme Gmbh</td><td class="patent-data-table-td ">Sustained release patch</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6143319">US6143319</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 30, 1997</td><td class="patent-data-table-td patent-date-value">Nov 7, 2000</td><td class="patent-data-table-td ">Lts Lohmann Therapie-Systeme Gmbh</td><td class="patent-data-table-td ">Transdermal therapeutic system containing estradiol</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6149935">US6149935</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 16, 1999</td><td class="patent-data-table-td patent-date-value">Nov 21, 2000</td><td class="patent-data-table-td ">Ortho-Mcneil Pharmaceutical, Inc.</td><td class="patent-data-table-td ">Solid matrix system for transdermal drug delivery</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6153216">US6153216</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 20, 1996</td><td class="patent-data-table-td patent-date-value">Nov 28, 2000</td><td class="patent-data-table-td ">Rotta Research B.V.</td><td class="patent-data-table-td ">Transdermal estradiol/progestogen agent patch and its production</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6221383">US6221383</a></td><td class="patent-data-table-td patent-date-value">May 25, 1999</td><td class="patent-data-table-td patent-date-value">Apr 24, 2001</td><td class="patent-data-table-td ">Noven Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Solubility parameter based drug delivery system and method for altering drug saturation concentration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6235306">US6235306</a></td><td class="patent-data-table-td patent-date-value">Mar 23, 1999</td><td class="patent-data-table-td patent-date-value">May 22, 2001</td><td class="patent-data-table-td ">Noven Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Solubility parameter based drug delivery system and method for altering drug saturation concentration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6274165">US6274165</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 3, 1998</td><td class="patent-data-table-td patent-date-value">Aug 14, 2001</td><td class="patent-data-table-td ">Lts Lohmann Therapie-Systeme Ag</td><td class="patent-data-table-td ">Patch for controlled delivery of oestradiol or its pharmaceutically acceptable derivatives</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6521250">US6521250</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 10, 2000</td><td class="patent-data-table-td patent-date-value">Feb 18, 2003</td><td class="patent-data-table-td ">Lts Lohmann Therapie-Systeme Gmbh</td><td class="patent-data-table-td ">Transdermal therapeutic system containing estradiol</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6555217">US6555217</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 27, 1999</td><td class="patent-data-table-td patent-date-value">Apr 29, 2003</td><td class="patent-data-table-td ">Henkel Kommanditgesellschaft Auf Aktien</td><td class="patent-data-table-td ">Self-supporting and redetachable adhesive article</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6899894">US6899894</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 8, 1999</td><td class="patent-data-table-td patent-date-value">May 31, 2005</td><td class="patent-data-table-td ">Lts Lohmann Therapie-Systeme Ag</td><td class="patent-data-table-td ">Mixture of oestradiol and norethisterone acetate applied to backing with pressure sensitive adhesive; protective coatings; multilayer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7223418">US7223418</a></td><td class="patent-data-table-td patent-date-value">Mar 5, 2001</td><td class="patent-data-table-td patent-date-value">May 29, 2007</td><td class="patent-data-table-td ">Tiejin Limited</td><td class="patent-data-table-td ">For percutaneous drug administration; does not irritate skin</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7309497">US7309497</a></td><td class="patent-data-table-td patent-date-value">Aug 21, 2001</td><td class="patent-data-table-td patent-date-value">Dec 18, 2007</td><td class="patent-data-table-td ">Schwarz Pharma Ag</td><td class="patent-data-table-td ">Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7632859">US7632859</a></td><td class="patent-data-table-td patent-date-value">Nov 17, 2003</td><td class="patent-data-table-td patent-date-value">Dec 15, 2009</td><td class="patent-data-table-td ">Schwarz Pharma Ag</td><td class="patent-data-table-td ">Iontophoretic delivery of rotigotine for the treatment of Parkinson&#39;s disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7964213">US7964213</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 11, 2003</td><td class="patent-data-table-td patent-date-value">Jun 21, 2011</td><td class="patent-data-table-td ">Nitto Denko Corporation</td><td class="patent-data-table-td ">Patch and production method thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8124122">US8124122</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 7, 2003</td><td class="patent-data-table-td patent-date-value">Feb 28, 2012</td><td class="patent-data-table-td ">Teikoku Seiyaku Co., Ltd.</td><td class="patent-data-table-td ">Female hormone-containing patch</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8211462">US8211462</a></td><td class="patent-data-table-td patent-date-value">Feb 6, 2004</td><td class="patent-data-table-td patent-date-value">Jul 3, 2012</td><td class="patent-data-table-td ">Ucb Pharma Gmbh</td><td class="patent-data-table-td ">Transdermal therapeutic system (TTS); cement matrix contains a hot-meltable adhesive in which the active substance Rotigotine ((-)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl)amino]-1-napththol) is dispersed and dissolved; solvent-free</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8221784">US8221784</a></td><td class="patent-data-table-td patent-date-value">Aug 19, 2009</td><td class="patent-data-table-td patent-date-value">Jul 17, 2012</td><td class="patent-data-table-td ">Agile Therapeutics, Inc.</td><td class="patent-data-table-td ">Transdermal hormone delivery system: compositions and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8221785">US8221785</a></td><td class="patent-data-table-td patent-date-value">Sep 10, 2009</td><td class="patent-data-table-td patent-date-value">Jul 17, 2012</td><td class="patent-data-table-td ">Agile Therapeutics, Inc.</td><td class="patent-data-table-td ">Transdermal hormone delivery system: compositions and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8246978">US8246978</a></td><td class="patent-data-table-td patent-date-value">Jul 10, 2008</td><td class="patent-data-table-td patent-date-value">Aug 21, 2012</td><td class="patent-data-table-td ">Agile Therapeutics, Inc.</td><td class="patent-data-table-td ">Dermal delivery device with reduced loss of its volatile components</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8246979">US8246979</a></td><td class="patent-data-table-td patent-date-value">Jul 22, 2003</td><td class="patent-data-table-td patent-date-value">Aug 21, 2012</td><td class="patent-data-table-td ">Ucb Pharma Gmbh</td><td class="patent-data-table-td ">Multilayer drug delivery system; protective foils, microreservoirs; silicone pressure sensitive adhesive; Parkinson&#39;s disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8246980">US8246980</a></td><td class="patent-data-table-td patent-date-value">Jul 28, 2003</td><td class="patent-data-table-td patent-date-value">Aug 21, 2012</td><td class="patent-data-table-td ">Ucb Pharma Gmbh</td><td class="patent-data-table-td ">Transdermal delivery system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8545872">US8545872</a></td><td class="patent-data-table-td patent-date-value">Feb 3, 2011</td><td class="patent-data-table-td patent-date-value">Oct 1, 2013</td><td class="patent-data-table-td ">Ucb Pharma Gmbh</td><td class="patent-data-table-td ">Device for the transdermal administration of a rotigotine base</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8617591">US8617591</a></td><td class="patent-data-table-td patent-date-value">Apr 27, 2012</td><td class="patent-data-table-td patent-date-value">Dec 31, 2013</td><td class="patent-data-table-td ">Ucb Pharma Gmbh</td><td class="patent-data-table-td ">Transdermal delivery system for the administration of rotigotine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8633178">US8633178</a></td><td class="patent-data-table-td patent-date-value">Nov 21, 2012</td><td class="patent-data-table-td patent-date-value">Jan 21, 2014</td><td class="patent-data-table-td ">Therapeuticsmd, Inc.</td><td class="patent-data-table-td ">Natural combination hormone replacement formulations and therapies</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8747888">US8747888</a></td><td class="patent-data-table-td patent-date-value">Jul 19, 2012</td><td class="patent-data-table-td patent-date-value">Jun 10, 2014</td><td class="patent-data-table-td ">Agile Therapeutics, Inc.</td><td class="patent-data-table-td ">Dermal delivery device with in situ seal</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20110124833">US20110124833</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 12, 2010</td><td class="patent-data-table-td patent-date-value">May 26, 2011</td><td class="patent-data-table-td ">Nitto Denko Corporation</td><td class="patent-data-table-td ">Medical pressure-sensitive adhesive composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1177786A1?cl=en">EP1177786A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 5, 2001</td><td class="patent-data-table-td patent-date-value">Feb 6, 2002</td><td class="patent-data-table-td ">Teijin Limited</td><td class="patent-data-table-td ">Stretchable patch</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1369112A1?cl=en">EP1369112A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 5, 2003</td><td class="patent-data-table-td patent-date-value">Dec 10, 2003</td><td class="patent-data-table-td ">Nitto Denko Corporation</td><td class="patent-data-table-td ">Percutaneous absorption-type pharmaceutical preparation and process for producing the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2377540A1?cl=en">EP2377540A1</a></td><td class="patent-data-table-td patent-date-value">Mar 31, 2010</td><td class="patent-data-table-td patent-date-value">Oct 19, 2011</td><td class="patent-data-table-td ">Hexal AG</td><td class="patent-data-table-td ">Transdermal patch containing 17-deacetyl norgestimate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2006008320A2?cl=en">WO2006008320A2</a></td><td class="patent-data-table-td patent-date-value">Jul 22, 2005</td><td class="patent-data-table-td patent-date-value">Jan 26, 2006</td><td class="patent-data-table-td ">Lisapharma Spa</td><td class="patent-data-table-td ">Device for transdermal delivery of active principles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011120704A1?cl=en">WO2011120704A1</a></td><td class="patent-data-table-td patent-date-value">Mar 31, 2011</td><td class="patent-data-table-td patent-date-value">Oct 6, 2011</td><td class="patent-data-table-td ">Hexal Ag</td><td class="patent-data-table-td ">Transdermal patch containing 17-deacetyl norgestimate</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S445000">424/445</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S448000">424/448</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S449000">424/449</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S447000">424/447</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S446000">424/446</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0015440000">A61L15/44</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C09J0007020000">C09J7/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0015160000">A61L15/16</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61M0037000000">A61M37/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031560000">A61K31/56</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0015580000">A61L15/58</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031565000">A61K31/565</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0009700000">A61K9/70</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K9/7061">A61K9/7061</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L15/58">A61L15/58</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=9RU7BAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/565">A61K31/565</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61L15/58</span>, <span class="nested-value">A61K31/565</span>, <span class="nested-value">A61K9/70E2B6B2</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Jun 2, 2009</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 2-8 ARE CANCELLED. CLAIM 1 IS DETERMINED TO BE PATENTABLE AS AMENDED. NEW CLAIMS 9-12 AND 13ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 21, 2006</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 10, 2004</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20031231</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 29, 2003</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">LTS LOHMANN THERAPIE-SYSTEME AG, GERMANY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNORS:HOFFMANN, KLEIN;CORDES, MECONI;WOLFF;REEL/FRAME:014953/0913</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19990917</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">LTS LOHMANN THERAPIE-SYSTEME AG LOHMANNSTRASSE 2D-</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 5, 2002</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 12, 1998</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 30, 1995</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U1YAOdHXKvex360pjo7hLPauGk3yg\u0026id=9RU7BAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2sXJRC1D1zvCIfeFUoXb1-8S8cWQ\u0026id=9RU7BAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U1GKDEC8RefW_ECrhREb3__PLsXLA","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Sustained_release.pdf?id=9RU7BAABERAJ\u0026output=pdf\u0026sig=ACfU3U2WqhHwieZttsujba-eWuL75q9seA"},"sample_url":"http://www.google.com/patents/reader?id=9RU7BAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>